comprehensive -WSS

comprehensive

author：explore 2025-09-06 04:42:08 - browse：8

Investment bank Goldman Sachs is jumping into the biotech world after raising $650 million to invest in privately held startups.

The bank announced Wednesday that it has closed its first-ever life sciences fund, called West Street Life Sciences I. The plan is to invest the money in genetic medicine, cell therapies, immunotherapies, synthetic biology and artificial intelligence startups, as well as diagnostics and life science tools companies.

First-time funds have been difficult to raise during the biotech downturn. Last year, around $11.6 billion was raised by 183 new VC funds, which was the lowest fundraising total for first-timers since 2013, according to Pitchbook. Around $25.6 billion had been raised by 556 first-time funds in 2022.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： FDA approves potent Eli Lilly obesity drug, Zepbound

knowledge

WSS

White House calls on federal agencies to crack down on AI abuses

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Bird flu reported in person exposed to presumably infected cattle

A clever new way to fix Medicaid and graduate medical education

Medicare Advantage 2025 payments will dip, Biden administration says

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Wikipedia

comprehensive

focus

Alkermes shareholders re

Harvard scientists, with Google, unveil the most detailed brain map ever

Psychedelics group wrestles with new pharma identity

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Hollywood unions extend contract negotiations for actors

Bird flu in dairy cattle: New measures to control spread to humans

Peter Hotez and the public health issue of online harassment

Florida Supreme Court upholds state's abortion ban

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Young boy dies in trial for Pfizer Duchenne gene therapy

focus

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

The Sacklers, horror, and ‘The Fall of the House of Usher’

The new shift in health care is toward less care

White House calls on federal agencies to crack down on AI abuses

Victims of gun violence feel impacts long after bullet wound

First Opinion on colorectal cancer screening: letter and response

knowledge

knowledge

leisure time

hotspot